Global Biobank Meta-Analysis Initiative: How CanPath is Powering Genetic Discovery Across Human Disease

The Global Biobank Meta-analysis Initiative (GBMI) unites 24 biobanks, including CanPath and its regional cohorts, with data from over 2.2 million people, to power global genetic discovery. By integrating diverse genetic info, GBMI improves disease risk prediction, advances personalized medicine, and boosts discoveries. CanPath contributes Canadian data, adding diversity and impact! Together, they’ve harmonized data, improved data on Read more about Global Biobank Meta-Analysis Initiative: How CanPath is Powering Genetic Discovery Across Human Disease[…]

CanPath Featured as one of Canada’s Most Successful Investments in Biobanking

CanPath was featured as one of Canada’s most successful investments in biobanking! 🩸💉 In an Open Access Government article, Francois Lamontagne, Paul Hebert, and Michelle Kho (Sepsis Canada) emphasize the critical role of biobanks in generating new insights into healthcare and disease management. They underscore the pitfalls of ‘classic’ biobanks, highlight the low-cost opportunity of ‘living’ biobank Read more about CanPath Featured as one of Canada’s Most Successful Investments in Biobanking[…]

ISBER Awards

Congratulations to our colleague, Dr. Peter Watson on the Award for Outstanding Achievement in Biobanking from the International Society for Biological and Environmental Repositories!! We’re fortunate to work with Dr. Watson in his role with CanPath. Dr. Watson is the Director of Biobanking and Biospecimen Research Services, staff pathologist and senior scientist with BC Cancer. He Read more about ISBER Awards[…]